Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

eugia us llc - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride injection is indicated for production of local or regional anesthesia by infiltration techniques, such as percutaneous injection, and by peripheral nerve block techniques such as brachial plexus and intercostal, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine hydrochloride is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. 

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

henry schein, inc. - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987), epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - lidocaine hydrochloride and epinephrine injection, usp is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection, by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

sintetica sa - lidocaine hydrochloride anhydrous (unii: ec2cnf7xfp) (lidocaine - unii:98pi200987) - lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

lifestar pharma llc - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride injection is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine hcl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

roche products (ireland) ltd - lidocaine hydrochloride monohydrate; ceftriaxone sodium - powder and solvent for solution for injection - 1 gram(s) - ceftriaxone

Malta - inglise - Malta Medicines Authority

septodont 58 rue du pont de créteil, 94100 saint maur des fosses, france - epinephrine, lidocaine hydrochloride - solution for injection - epinephrine 12.5 µg/ml lidocaine hydrochloride 20 mg/ml - anesthetics

Kanada - inglise - Health Canada

carestream health canada company - epinephrine bitartrate; lidocaine hydrochloride - solution - 0.01mg; 20mg - epinephrine bitartrate 0.01mg; lidocaine hydrochloride 20mg - local anesthetics

Kanada - inglise - Health Canada

carestream health canada company - epinephrine bitartrate; lidocaine hydrochloride - solution - 0.02mg; 20mg - epinephrine bitartrate 0.02mg; lidocaine hydrochloride 20mg - local anesthetics

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

glenmark pharmaceuticals inc., usa - raloxifene hydrochloride (unii: 4f86w47br6) (raloxifene - unii:yx9162eo3i) - raloxifene hydrochloride 60 mg - raloxifene hydrochloride tablets are indicated for the treatment and prevention of osteoporosis in postmenopausal women [see clinical studies (14.1, 14.2)]. raloxifene hydrochloride tablets are indicated for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis [see clinical studies (14.3)]. raloxifene hydrochloride tablets are indicated for the reduction in risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer [see clinical studies (14.4)] . the effect in the reduction in the incidence of breast cancer was shown in a study of postmenopausal women at high risk for breast cancer with a 5-year planned duration with a median follow-up of 4.3 years [see clinical studies (14.4)]. twenty-seven percent of the participants received drug for 5 years. the long-term effects and the recommended length of treatment are not known. high risk of breast cancer is defined as at least one breast biopsy showing lobular carcinoma in situ (lcis) or atypic

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

general injectables and vaccines, inc. - lidocaine hydrochloride anhydrous (unii: ec2cnf7xfp) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 10 mg in 1 ml - xylocaine (lidocaine hcl) injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine hcl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.